glp 1 liver enzymes Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Frontiers | GLP-1 Receptor Agonists:
Description
Hattori Y, Jojima T, Tomizawa A, et al
PLoS ONE 9 , e91163 (2014)
Kielgast U, Krarup T, Holst JJ, Madsbad S
Nobody yet knows whether these effects are temporary, dose-related or limited to a subset of users
Like Ozempic, to qualify for phentermine you need to have a BMI over 30 or have a BMI of over 27 with a weight-related condition (13)
